stocks

Stock Market Today: Growth Takes a Backseat to Value Yet Again

A violent rotation from tech and other growth stocks, and into value names, continued Tuesday as a COVID drug received an emergency-use green light.

A rotation away from growth and into value continued apace Tuesday amid more news on the COVID front.

Less than 24 hours after Pfizer (PFE, -1.3%) and BioNTech (BNTX, +7.6%) released promising trial data for their vaccine candidate, the U.S. Food and Drug Administration approved Eli Lilly's (LLY, +3.0%) antibody treatment on an emergency-use basis.

"Yesterday after market close, LLY announced that its monoclonal antibody treatment (LY-CoV555) received FDA Emergency Use Authorization (EUA) based on positive findings from the BLAZE-1 Phase 2 studies to treat patients with mild to moderate Covid-19 cases after immediate diagnosis," writes CFRA analyst Sel Hardy (Buy). "As daily new Covid-19 infections and hospitalizations reach unprecedented highs, we think the EUA opens a considerable market opportunity for LLY," adding that AmerisourceBergen (ABC, +3.7%) will be in charge of U.S. delivery.

That continued a trend of investors moving money from heavily bought growth stocks to battered cyclical plays.

The Dow Jones Industrial Average climbed 0.9% on Tuesday, to another new high of 29,420, led by the likes of Walgreens (WBA, +6.5%) and Boeing (BA, +5.2%), the latter rising amid reports that the government regulators are nearly finished with their review of proposed changes to the troubled 737-MAX aircraft. But the Nasdaq Composite suffered another big drop, losing 1.4% to 11,553.

Other action in the stock market today:

  • The S&P 500 slipped by 0.1% to 3,545.
  • Small caps had a day, as the Russell 2000 gained 1.9% to a fresh high of 1,737.
  • Gold futures improved by 1.2%, settling at $1,876.40 per ounce.
  • U.S. crude oil futures also settled higher, improving 2.9% to $43.61 per barrel.

Several Trends Could Be Here to Stay, However

A team of UBS strategists believe the rotation has more room to run: "After Monday's (and last week's) strong moves, we find that … US Growth stocks are pricing in the most hope of normalization, while European and US Value stocks are pricing in the least, and therefore should have more upside potential," they write.

But don't expect the coming months and 2021 to completely flip the script.

We could also see a continuation of several trends that blossomed over the past few months. For instance, the earnings calendar included a big win from D.R. Horton (DHI, +9.1), which reported a quarterly profit beat and raised its dividend, putting more fuel behind 2020's rally in housing-market stocks. A second-half resurgence in initial public offerings (IPOs) should remain strong, thanks to several big-name offerings expected to go live by the end of this year and throughout 2021.

And we could see continued outperformance by one of the market's most ignored sectors: materials stocks.

While metals miners and chemical producers don't tell scintillating stories, they've got what counts: an improving macroeconomic picture, often low valuations and, in some cases, decent dividend programs. While they've also been outperforming for several months now, the "great rotation" should still benefit many of these value-priced materials stocks.

Kyle Woodley was long BA as of this writing.

Most Popular

Your Guide to Roth Conversions
Special Report
Tax Breaks

Your Guide to Roth Conversions

A Kiplinger Special Report
February 25, 2021
How to Know When You Can Retire
retirement

How to Know When You Can Retire

You’ve scrimped and saved, but are you really ready to retire? Here are some helpful calculations that could help you decide whether you can actually …
January 5, 2022
The 10 Best Closed-End Funds (CEFs) for 2022
CEFs

The 10 Best Closed-End Funds (CEFs) for 2022

These high-yielding CEFs won't just significantly boost your portfolio income. They'll also allow you to buy their underlying stocks and bonds at a di…
January 12, 2022

Recommended

Could the Stock Market Crash for Real? Here’s How to Prepare
investing

Could the Stock Market Crash for Real? Here’s How to Prepare

After a long march to record heights, the stock market tripped into correction territory in January. How should you react? Thoughtfully.
January 25, 2022
The 60/40 Portfolio Is Dead. Long Live 33/33/33.
investing

The 60/40 Portfolio Is Dead. Long Live 33/33/33.

A portfolio of stocks and bonds used to be the gold standard, but it just doesn’t cut it anymore. It’s time to throw some alternative investments into…
January 25, 2022
Stock Market Today (1/24/22): Dow Erases 1,100-Point Intraday Drop to End Higher
Stock Market Today

Stock Market Today (1/24/22): Dow Erases 1,100-Point Intraday Drop to End Higher

The S&P 500 was on pace to close in correction territory before reversing higher.
January 24, 2022
Tesla Stock: TSLA Headlines Busiest Week of Earnings So Far
stocks

Tesla Stock: TSLA Headlines Busiest Week of Earnings So Far

Our preview of the upcoming week's earnings reports includes Tesla (TSLA), Apple (AAPL), Microsoft (MSFT), Intel (INTC) and Chevron (CVX).
January 24, 2022